Protara Therapeutics, Inc.
TARA
$3.97
-$0.07-1.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.78M | -17.31M | -13.26M | -14.96M | -11.91M |
| Total Depreciation and Amortization | 90.00K | 93.00K | 88.00K | 98.00K | 83.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.46M | 995.00K | 924.00K | 804.00K | 930.00K |
| Change in Net Operating Assets | -5.11M | -731.00K | -206.00K | 1.81M | -3.81M |
| Cash from Operations | -21.34M | -16.95M | -12.45M | -12.25M | -14.71M |
| Capital Expenditure | -- | -24.00K | -4.00K | -22.00K | -44.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.72M | -26.88M | -6.50M | -47.70M | -58.31M |
| Cash from Investing | -14.72M | -26.91M | -6.51M | -47.72M | -58.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.94M | 81.18M | -- | 222.00K | 2.74M |
| Repurchase of Common Stock | -272.00K | 0.00 | -201.00K | 0.00 | -185.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -526.00K | -214.00K | 214.00K | -214.00K | -828.00K |
| Cash from Financing | 1.14M | 80.96M | 13.00K | 8.00K | 1.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.92M | 37.11M | -18.95M | -59.97M | -71.34M |